Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testicular Neoplasms | 10 | 2017 | 20 | 1.850 |
Why?
|
| Wilms Tumor | 7 | 2011 | 10 | 1.170 |
Why?
|
| Ureteral Obstruction | 7 | 2008 | 15 | 1.110 |
Why?
|
| Kidney Neoplasms | 7 | 2011 | 75 | 1.100 |
Why?
|
| Child | 32 | 2017 | 1171 | 1.010 |
Why?
|
| Ureter | 6 | 2008 | 27 | 0.940 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 5 | 2017 | 6 | 0.930 |
Why?
|
| Nephrectomy | 8 | 2011 | 37 | 0.910 |
Why?
|
| Urologists | 2 | 2016 | 3 | 0.650 |
Why?
|
| Infant | 22 | 2017 | 486 | 0.600 |
Why?
|
| Child, Preschool | 19 | 2017 | 578 | 0.600 |
Why?
|
| Hypospadias | 4 | 2010 | 4 | 0.580 |
Why?
|
| Urinary Fistula | 2 | 2008 | 3 | 0.550 |
Why?
|
| Kidney Pelvis | 4 | 2008 | 12 | 0.550 |
Why?
|
| Pediatricians | 1 | 2016 | 3 | 0.520 |
Why?
|
| Male | 41 | 2017 | 12556 | 0.510 |
Why?
|
| Urology | 2 | 2015 | 15 | 0.510 |
Why?
|
| Health Care Surveys | 1 | 2016 | 62 | 0.510 |
Why?
|
| Attitude of Health Personnel | 2 | 2016 | 139 | 0.510 |
Why?
|
| Medical Oncology | 1 | 2016 | 43 | 0.500 |
Why?
|
| Humans | 49 | 2017 | 23169 | 0.480 |
Why?
|
| Orchiectomy | 2 | 2015 | 4 | 0.480 |
Why?
|
| Physician's Role | 1 | 2015 | 14 | 0.470 |
Why?
|
| Urethra | 5 | 2010 | 14 | 0.470 |
Why?
|
| Urinary Bladder | 3 | 2006 | 18 | 0.460 |
Why?
|
| Vesico-Ureteral Reflux | 4 | 2001 | 5 | 0.460 |
Why?
|
| Kidney | 4 | 2006 | 142 | 0.450 |
Why?
|
| Laparoscopy | 4 | 2010 | 183 | 0.440 |
Why?
|
| Cystostomy | 3 | 2004 | 5 | 0.440 |
Why?
|
| Testicular Diseases | 2 | 2010 | 13 | 0.420 |
Why?
|
| Neoplasms | 1 | 2015 | 219 | 0.390 |
Why?
|
| Urologic Surgical Procedures, Male | 4 | 2010 | 23 | 0.380 |
Why?
|
| Cutaneous Fistula | 2 | 2010 | 3 | 0.380 |
Why?
|
| Cryptorchidism | 2 | 2010 | 3 | 0.370 |
Why?
|
| Adolescent | 14 | 2017 | 1916 | 0.360 |
Why?
|
| Ovarian Neoplasms | 3 | 2017 | 78 | 0.360 |
Why?
|
| Neoplasm Seeding | 1 | 2011 | 9 | 0.350 |
Why?
|
| Intraoperative Complications | 1 | 2011 | 58 | 0.330 |
Why?
|
| Hydronephrosis | 3 | 2008 | 6 | 0.330 |
Why?
|
| Lithiasis | 1 | 2010 | 2 | 0.330 |
Why?
|
| Infant, Newborn | 9 | 2017 | 538 | 0.310 |
Why?
|
| Preoperative Care | 1 | 2009 | 110 | 0.300 |
Why?
|
| Urethral Diseases | 1 | 2008 | 3 | 0.290 |
Why?
|
| Polyps | 1 | 2008 | 3 | 0.290 |
Why?
|
| Ureteral Neoplasms | 1 | 2008 | 5 | 0.290 |
Why?
|
| Prenatal Diagnosis | 1 | 2008 | 10 | 0.280 |
Why?
|
| Rectal Fistula | 1 | 2006 | 1 | 0.260 |
Why?
|
| Anal Canal | 1 | 2006 | 3 | 0.260 |
Why?
|
| Abnormalities, Multiple | 1 | 2006 | 13 | 0.260 |
Why?
|
| Fetus | 1 | 2004 | 31 | 0.220 |
Why?
|
| Cystitis | 1 | 2004 | 11 | 0.220 |
Why?
|
| Eosinophilia | 1 | 2004 | 35 | 0.210 |
Why?
|
| Female | 19 | 2017 | 13059 | 0.200 |
Why?
|
| Registries | 2 | 2002 | 172 | 0.190 |
Why?
|
| Pediatrics | 2 | 2015 | 38 | 0.160 |
Why?
|
| Combined Modality Therapy | 3 | 2009 | 295 | 0.150 |
Why?
|
| Societies, Medical | 2 | 2016 | 119 | 0.150 |
Why?
|
| Surgical Flaps | 2 | 2010 | 50 | 0.150 |
Why?
|
| Pregnancy | 3 | 2008 | 321 | 0.150 |
Why?
|
| Urinary Tract Infections | 1 | 1999 | 31 | 0.150 |
Why?
|
| Lymphedema | 1 | 1998 | 4 | 0.150 |
Why?
|
| Testis | 3 | 2015 | 9 | 0.150 |
Why?
|
| Genital Diseases, Male | 1 | 1998 | 6 | 0.150 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1998 | 24 | 0.140 |
Why?
|
| Choristoma | 1 | 1998 | 4 | 0.140 |
Why?
|
| Gonadal Dysgenesis | 1 | 2017 | 1 | 0.140 |
Why?
|
| Christianity | 1 | 1997 | 5 | 0.140 |
Why?
|
| Religion and Medicine | 1 | 1997 | 25 | 0.140 |
Why?
|
| Testicular Hydrocele | 2 | 1999 | 5 | 0.130 |
Why?
|
| Urologic Surgical Procedures | 1 | 2016 | 8 | 0.130 |
Why?
|
| Surgical Oncology | 1 | 2016 | 6 | 0.130 |
Why?
|
| Neoplasm Staging | 4 | 2017 | 359 | 0.130 |
Why?
|
| Adult | 12 | 2017 | 7031 | 0.120 |
Why?
|
| Postoperative Complications | 5 | 2010 | 824 | 0.120 |
Why?
|
| United States | 2 | 2016 | 1820 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 97 | 0.120 |
Why?
|
| Replantation | 1 | 1995 | 9 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 240 | 0.120 |
Why?
|
| Data Collection | 1 | 2014 | 83 | 0.110 |
Why?
|
| Retrospective Studies | 4 | 2014 | 3026 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 203 | 0.100 |
Why?
|
| Epidermal Cyst | 1 | 1993 | 5 | 0.100 |
Why?
|
| Kidney Transplantation | 1 | 1994 | 114 | 0.100 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 2 | 2002 | 3 | 0.100 |
Why?
|
| Abdomen | 1 | 1992 | 7 | 0.090 |
Why?
|
| Scrotum | 1 | 1992 | 12 | 0.090 |
Why?
|
| Disease-Free Survival | 3 | 2017 | 171 | 0.090 |
Why?
|
| Penis | 3 | 2009 | 72 | 0.090 |
Why?
|
| Risk Factors | 3 | 2017 | 1988 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2015 | 2971 | 0.090 |
Why?
|
| Time Factors | 3 | 2008 | 1275 | 0.090 |
Why?
|
| Balanitis Xerotica Obliterans | 1 | 2010 | 1 | 0.090 |
Why?
|
| Ultrasonography | 2 | 2010 | 203 | 0.080 |
Why?
|
| Urethral Stricture | 1 | 2010 | 7 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2017 | 1512 | 0.080 |
Why?
|
| Kidney Calices | 1 | 1990 | 1 | 0.080 |
Why?
|
| Circumcision, Male | 2 | 2000 | 5 | 0.080 |
Why?
|
| Endodermal Sinus Tumor | 2 | 2002 | 3 | 0.080 |
Why?
|
| Survival Rate | 2 | 2017 | 323 | 0.080 |
Why?
|
| Sexual Development | 1 | 2009 | 1 | 0.080 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2009 | 2 | 0.080 |
Why?
|
| Fertility | 1 | 2009 | 17 | 0.080 |
Why?
|
| Follow-Up Studies | 5 | 2015 | 1427 | 0.070 |
Why?
|
| Prevalence | 1 | 2010 | 384 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2011 | 552 | 0.070 |
Why?
|
| Age Factors | 2 | 2009 | 639 | 0.070 |
Why?
|
| Congenital Abnormalities | 1 | 2008 | 6 | 0.070 |
Why?
|
| Twins | 1 | 2008 | 8 | 0.070 |
Why?
|
| Young Adult | 2 | 2010 | 1671 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2006 | 51 | 0.060 |
Why?
|
| Prognosis | 2 | 2015 | 740 | 0.060 |
Why?
|
| Infant, Premature | 1 | 2008 | 181 | 0.060 |
Why?
|
| Disease Progression | 1 | 2008 | 523 | 0.060 |
Why?
|
| Multicystic Dysplastic Kidney | 1 | 2005 | 1 | 0.060 |
Why?
|
| alpha-Fetoproteins | 2 | 2002 | 3 | 0.060 |
Why?
|
| Papilloma | 1 | 2005 | 4 | 0.060 |
Why?
|
| Middle Aged | 6 | 2016 | 8000 | 0.060 |
Why?
|
| Sheep | 1 | 2004 | 16 | 0.060 |
Why?
|
| Uterus | 1 | 2004 | 17 | 0.060 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2005 | 33 | 0.060 |
Why?
|
| Recurrence | 2 | 2010 | 272 | 0.060 |
Why?
|
| Urinary Bladder Diseases | 1 | 2004 | 7 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2004 | 210 | 0.050 |
Why?
|
| Sertoli Cell Tumor | 1 | 2002 | 1 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 811 | 0.050 |
Why?
|
| Animals | 3 | 2009 | 3272 | 0.050 |
Why?
|
| Sports | 1 | 2002 | 28 | 0.050 |
Why?
|
| Patient Education as Topic | 2 | 2002 | 123 | 0.050 |
Why?
|
| Aged | 4 | 2016 | 7498 | 0.040 |
Why?
|
| Athletic Injuries | 1 | 2002 | 126 | 0.040 |
Why?
|
| Suture Techniques | 1 | 2001 | 105 | 0.040 |
Why?
|
| Neoplasms, Second Primary | 1 | 2001 | 36 | 0.040 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 45 | 0.040 |
Why?
|
| Algorithms | 1 | 2002 | 310 | 0.040 |
Why?
|
| Prune Belly Syndrome | 1 | 1999 | 1 | 0.040 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 1999 | 3 | 0.040 |
Why?
|
| Spermatozoa | 1 | 1999 | 8 | 0.040 |
Why?
|
| Infertility, Male | 1 | 1999 | 6 | 0.040 |
Why?
|
| Hernia, Inguinal | 1 | 1999 | 18 | 0.040 |
Why?
|
| Teaching Materials | 1 | 1999 | 9 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1999 | 6 | 0.040 |
Why?
|
| Vena Cava, Inferior | 1 | 1999 | 9 | 0.040 |
Why?
|
| Urography | 1 | 1998 | 3 | 0.040 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 1998 | 5 | 0.040 |
Why?
|
| Hemodilution | 1 | 1997 | 2 | 0.040 |
Why?
|
| Hemostasis, Surgical | 1 | 1997 | 11 | 0.030 |
Why?
|
| Varicocele | 1 | 1997 | 3 | 0.030 |
Why?
|
| Teratoma | 1 | 1997 | 3 | 0.030 |
Why?
|
| Stents | 1 | 1998 | 77 | 0.030 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1997 | 40 | 0.030 |
Why?
|
| Bleomycin | 1 | 2017 | 2 | 0.030 |
Why?
|
| Etoposide | 1 | 2017 | 27 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2000 | 289 | 0.030 |
Why?
|
| North America | 1 | 2016 | 32 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 153 | 0.030 |
Why?
|
| Cisplatin | 1 | 2017 | 60 | 0.030 |
Why?
|
| Certification | 1 | 2016 | 24 | 0.030 |
Why?
|
| Surgeons | 1 | 2016 | 76 | 0.030 |
Why?
|
| Watchful Waiting | 1 | 2015 | 10 | 0.030 |
Why?
|
| Graft Survival | 1 | 1994 | 84 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 1993 | 27 | 0.020 |
Why?
|
| Retroperitoneal Space | 1 | 1992 | 8 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2010 | 18 | 0.020 |
Why?
|
| Parabiosis | 1 | 1990 | 2 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 1998 | 3754 | 0.020 |
Why?
|
| Renal Artery Obstruction | 1 | 1990 | 3 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 1990 | 27 | 0.020 |
Why?
|
| Thrombosis | 1 | 1990 | 52 | 0.020 |
Why?
|
| Semen Analysis | 1 | 2009 | 1 | 0.020 |
Why?
|
| Sperm Count | 1 | 2009 | 5 | 0.020 |
Why?
|
| Epididymis | 1 | 2009 | 6 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2009 | 277 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 357 | 0.020 |
Why?
|
| Reoperation | 1 | 2010 | 743 | 0.020 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2005 | 3 | 0.010 |
Why?
|
| Colposcopy | 1 | 2005 | 3 | 0.010 |
Why?
|
| Electrocoagulation | 1 | 2005 | 7 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 1232 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2005 | 73 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 320 | 0.010 |
Why?
|
| Risk | 1 | 2002 | 161 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 590 | 0.010 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2001 | 2 | 0.010 |
Why?
|
| Survivors | 1 | 2001 | 69 | 0.010 |
Why?
|
| Endoscopes | 1 | 2000 | 9 | 0.010 |
Why?
|
| Tissue Adhesions | 1 | 2000 | 9 | 0.010 |
Why?
|
| Suction | 1 | 1999 | 33 | 0.010 |
Why?
|
| Puberty | 1 | 1997 | 11 | 0.010 |
Why?
|
| Ligation | 1 | 1997 | 37 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1996 | 69 | 0.010 |
Why?
|
| Inulin | 1 | 1990 | 1 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 1990 | 6 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1990 | 13 | 0.010 |
Why?
|
| Creatinine | 1 | 1990 | 40 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 1990 | 34 | 0.010 |
Why?
|
| Rats | 1 | 1990 | 625 | 0.000 |
Why?
|